Form 4 for RMD ResMed|
Accepted 2021-11-15 00:00:00 ET · period of report 2021-11-11 · accession 0001127602-21-029088 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-15 | 2021-11-11 | RMD | Farrell Michael J. | CEO | F - Tax | $259.47 | -8,748 | 416.0K | -2% | -$2.27M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2021-11-11 | F | D | 8,748 | $259.47 | 415,958 | D | — | — | (F2) Includes 94.5633 shares of ResMed stock purchased on October 29, 2021, through the ResMed Employee Stock Purchase Plan. |